نتائج البحث - Tzu-yin Lin
- يعرض 1 - 11 نتائج من 11
-
1
-
2
Peptide-based materials for cancer immunotherapy حسب Lu Zhang, Yanyu Huang, Aaron Lindstrom, Tzu‐yin Lin, Kit S. Lam, Yuanpei Li
منشور في 2019Revisão -
3
-
4
-
5
AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit حسب Tzu‐yin Lin, Joelle M. Fenger, Sridhar Murahari, Misty D. Bear, Samuel K. Kulp, Dasheng Wang, Ching-Shih Chen, William C. Kisseberth, Cheryl A. London
منشور في 2010Artigo -
6
Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment حسب Xiangdong Xue, Yee Huang, Ruonan Bo, Bei Jia, Hao Wu, Ye Yuan, Zhongling Wang, Zhao Ma, Di Jing, Xiaobao Xu, Weimin Yu, Tzu‐yin Lin, Yuanpei Li
منشور في 2018Artigo -
7
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy حسب Chong-xian Pan, Hongyong Zhang, Clifford G. Tepper, Tzu‐yin Lin, Ryan R. Davis, James Keck, P. Ghosh, Parkash S. Gill, Susan Airhart, Carol Bult, David R. Gandara, Edison Liu, Ralph W. de Vere White
منشور في 2015Artigo -
8
Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy حسب Zhao Ma, Jin Li, Kai Lin, Mythili Ramachandran, Dalin Zhang, Megan R. Showalter, Cristabelle De Souza, Aaron Lindstrom, Lucas N. Solano, Bei Jia, Shiro Urayama, Yuyou Duan, Oliver Fiehn, Tzu-yin Lin, Minyong Li, Yuanpei Li
منشور في 2020Artigo -
9
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer حسب Shuxiong Zeng, Yanjun Zhu, Ai-Hong Ma, Weimin Yu, Hongyong Zhang, Tzu‐yin Lin, Wei Shi, Clifford G. Tepper, Paul T. Henderson, Susan Airhart, Jian-Ming Guo, Chuan-Liang Xu, Ralph W. deVere White, Chong-xian Pan
منشور في 2017Artigo -
10
Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging حسب Zhongling Wang, Xiangdong Xue, Hongwei Lu, Yixuan He, Ziwei Lu, Zhijie Chen, Ye Yuan, Na Tang, Courtney A. Dreyer, Lizabeth Quigley, N. J. Curro, Kit S. Lam, Jeffrey H. Walton, Tzu‐yin Lin, Angelique Y. Louie, Dustin A. Gilbert, Kai Liu, Katherine W. Ferrara, Yuanpei Li
منشور في 2020Artigo -
11
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells حسب Demet Candas-Green, Bowen Xie, Jie Huang, Ming Fan, Aijun Wang, Cheikh Menaa, Yanhong Zhang, Lu Zhang, Di Jing, Soheila Azghadi, Weibing Zhou, Lin Liu, Nian Jiang, Tao Li, Tianyi Gao, Colleen Sweeney, Rulong Shen, Tzu‐yin Lin, Chong‐Xian Pan, Omer M. Ozpiskin, Gayle E. Woloschak, David J. Grdina, Andrew Vaughan, Ji Ming Wang, Shuli Xia, Arta M. Monjazeb, William J. Murphy, Lun-Quan Sun, Hong-Wu Chen, Kit S. Lam, Ralph R. Weichselbaum, Jian Jian Li
منشور في 2020Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Biochemistry
Cancer
Cancer research
Internal medicine
Biology
Gene
Immunology
Chemistry
Materials science
Nanotechnology
Bladder cancer
Cell biology
Mast cell
Nanomedicine
Nanoparticle
Apoptosis
Breast cancer
Cancer immunotherapy
Cell culture
Cell growth
Computer science
Drug delivery
Genetics
Heat shock protein
Hsp90
Hsp90 inhibitor
Immune system
Immunotherapy
In vitro